Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 266, Issue 1-2, Pages 43-48Publisher
ELSEVIER
DOI: 10.1016/j.jneuroim.2013.10.011
Keywords
Intravenous immunoglobulin preparation (IVIG); Experimental autoimmune neuritis (EAN); Macrophage inflammatory protein-1 alpha (MIP-1 alpha); Chronic inflammatory demyelinating; polyneuropathy (CIDP)
Categories
Ask authors/readers for more resources
To clarify the mechanism of action of an intravenous immunoglobulin (IVIG) preparation in chronic inflammatory demyelinating polyneuropathy, the effects of IVIG were investigated using an experimental autoimmune neuropathy model in the rat. IVIG significantly suppressed the progression of neurologic signs and sciatic nerve conduction velocity with the inhibition of inflammatory cell infiltration, mainly of macrophages, to the peripheral nerves. A significant suppressive effect on the expression of macrophage inflammatory protein 1-alpha (MIP-1 alpha) was simultaneously observed in the nerves. These results suggest that IVIG is effective for inflammatory demyelinating polyneuropathy by inhibiting the chemotactic factor of macrophages. (c) 2013 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available